ePrints

Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications - reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

Lookup NU author(s): Dr Chris LambORCiD, Dr Marcus Brookes, Dr Sesha Subramanian

Downloads

• Accepted version [.pdf]

Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Wiley-Blackwell Publishing Ltd., 2021.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Lamb CA, Sebastian S, Kent AJ, Segal JP, Gonzalez HA, Brookes MJ, Mehta SJ, Subramanian S, Bhala N, Hicks LC, Conley TE, Patel KV, Walker GJ, Kennedy NA

Publication type: Article

Publication status: Published

Journal: Alimentary Pharmacology & Therapeutics

Year: 2021

Volume: 53

Issue: 11

Pages: 1236-1240

Print publication date: 01/06/2021

Online publication date: 07/05/2021

Acceptance date: 11/03/2021

Date deposited: 11/03/2021

ISSN (print): 0269-2813

ISSN (electronic): 1365-2036

Publisher: Wiley-Blackwell Publishing Ltd.

URL: https://doi.org/10.1111/apt.16349

DOI: 10.1111/apt.16349

Altmetrics

Share